An Observational Post-Authorization Modified Prescription-Event Monitoring Safety Study To Monitor The Safety And Utilization Of Asenapine (Sycrest) In The Primary Care Setting In EnglandFirst published 11/03/2013 Last updated 31/03/2024 EU PAS number: EUPAS3603StudyFinalised